转导管 mitra 门更换或修复为 mitra 吐:一个叙事审查
Michail Penteris1, Anastasia Kalogirou1, Konstantinos Lampropoulos2,3
1Department of Medicine, Democritus University of Thrace, Alexandroupolis, Dragana GR-68100 Greece.
Indian journal of thoracic and cardiovascular surgery
|September 23, 2025
概括
由于手术风险较低,在高风险的甲状腺吐 (MR) 时,转导管甲状腺修复 (TMVr) 是首选的. 过导管 mitra 置换 (TMVR) 显示出更大的 MR 减少和症状改善,具有类似的长期存活率.
科学领域:
- 心血管医学 心血管医学
- 干预心脏病学 干预心脏病学
背景情况:
- 全球腹反 (MR) 的负担正在上升.
- 过导管 mitra 门修复 (TMVr) 是高风险患者的标准.
- 过导管 mitra 置换 (TMVR) 是一个新兴的替代方案.
研究的目的:
- 综合 TMVr 与 MR 的 TMVR 的比较证据.
- 专注于程序结果,临床有效性和患者选择.
- 评估这些跨导管干预措施的现有证据.
主要方法:
- 对比研究的叙述性审查.
- 在PubMed和Cochrane图书馆搜索到2025年2月28日.
- 包括三项观察性研究,涉及4322名MR患者.
主要成果:
- TMVR与较高的短期死亡率和并发症有关.
- TMVR显示了更大的MR减少和症状改善.
- 在TMVr和TMVR之间长期死亡率没有显著差异.
结论:
- 由于程序风险较低,目前更喜欢TMVr.
- TMVR可能提供更持久的MR减少和症状缓解.
- 迫切需要改进患者选择和进一步进行比较试验.
相关概念视频
Mitral Regurgitation III: Medical Management
284
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
284
Mitral Stenosis III: Medical Management
247
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
247
Mitral Regurgitation IV: Nursing Management
311
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
311
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
381
Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
381
Mitral Regurgitation I: Introduction
423
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
423
Mitral Valve Prolapse II: Assessment and Management
438
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
438


